HyGro,
Have you ever been on a roller coaster ride? Lots of ups and downs and yet this particular shareholder is still up considerably just by using cost averaging over the years and not selling. You see HyGro, unlike your insinuations, I knew NWBO was going to do very well over time and called the long term double bottom on NWBO stock in 2020. Since that time the initial $.01/ month increase uptrend has held even on May 10th. Unlike you, I have shared with the board that there is another uptrend way above the one we are on now that will become visible when an approval time frame becomes certain and or a partnership is announced. Unlike you, Sojourner55 shared the downtrend in NVCR from the top end signals on this board.
I have no problem with folks wanting to be invested in companies trying to help find ways for people to overcome fatal diseases and even though Optune is not an ideal help, it may end up helping some using combos. DCVax-L data is very good as there are many more patients alive than otherwise would be. The issue for approval is that the process for commercial manufacturing has been trying to catch up to expected demand from a treatment that can be enhanced to make long term survival in GBM approach 50% or more. Anyone not excited about that for the patients and the chance for improved results without chemo in some patients shows their true colors. So while you try to convince that this trial will not pass muster, true longs and patients anxiously await the impact of manufacturing news because once manufacturing is ready and NWBO announces a successful trial and other news ensues, patient demand will soar and if approval news does not follow soon after regulators would be placed under immense pressure. Unlike you, I think they all have figured this out long ago and are ready. Then again, unlike you, I supported the call of the long term double bottom in 2020 and had Adam respond to a comment I made about Direct with his own comment about it being no better than grapefruit juice. I guess grapefruit juice leads to 8 year survival from pallative care in pancreatic and other cancers huh?; ). Best wishes.
Market Data 
Markets 
AI
